BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16965389)

  • 1. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
    Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
    Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
    Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
    Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.
    Vega-Ostertag M; Casper K; Swerlick R; Ferrara D; Harris EN; Pierangeli SS
    Arthritis Rheum; 2005 May; 52(5):1545-54. PubMed ID: 15880836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
    Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
    Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
    Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
    Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class I antibody: preliminary data.
    Naji A; Deschaseaux F; Racadot E; Ferrand C; Justrabo E; Guignier F; Mousson C; Rifle G
    Transplant Proc; 2005; 37(6):2892-3. PubMed ID: 16182846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
    Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
    J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of tissue factor induced by IL-6 in HUVEC].
    Tang XL; Jiang ZY; Dong J; Liu XC; Cai SY; Xiao R; Lu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):234-7. PubMed ID: 16608083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.
    Stannard AK; Khurana R; Evans IM; Sofra V; Holmes DI; Zachary I
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):494-502. PubMed ID: 17170373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models.
    Pierangeli SS; Liu X; Espinola R; Olee T; Zhu M; Harris NE; Chen PP
    Thromb Haemost; 2000 Sep; 84(3):388-95. PubMed ID: 11019960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1.
    Atsumi T; Khamashta MA; Haworth RS; Brooks G; Amengual O; Ichikawa K; Koike T; Hughes GR
    Arthritis Rheum; 1998 May; 41(5):800-7. PubMed ID: 9588730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
    Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
    Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies.
    Pierangeli SS; Vega-Ostertag M; Harris EN
    Thromb Res; 2004; 114(5-6):467-76. PubMed ID: 15507280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
    Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
    J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome.
    López-Pedrera C; Aguirre MA; Buendía P; Barbarroja N; Ruiz-Limón P; Collantes-Estevez E; Velasco F; Khamashta M; Cuadrado MJ
    Arthritis Rheum; 2010 Mar; 62(3):869-77. PubMed ID: 20131237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies.
    Lázaro I; Carmona F; Reverter JC; Cervera R; Tassies D; Balasch J
    Am J Obstet Gynecol; 2009 Jul; 201(1):87.e1-6. PubMed ID: 19427615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of CD36 in monocyte activation by antiphospholipid antibodies.
    Kato M; Atsumi T; Oku K; Amengual O; Nakagawa H; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T
    Lupus; 2013 Jul; 22(8):761-71. PubMed ID: 23817509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.